RWJ-351647

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRWJ-351647
Drug Alias NameSPD-556M-0002RWJ-351647
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V2 receptor antagonists
TargetsVasopressin V2 receptor
Therapy Area/IndicationsAscites
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMovetis
Active IndicationsN/A
Inactive IndicationsAscites

Other Information

ATC CodeN/A
Related LinksN/A